NGS

Alamar Biosciences, Inc. is a proteomics company based in Fremont, California, that develops technologies for protein biomarker detection. Its offerings include the ARGO HT System, an all-in-one automated instrument with onboard qPCR, and NULISA assays for immunology, neurology, and oncology, along with custom assay development and data analysis solutions.

automationcustom assay developmentdata analysismultiplex biomarker analysisproteomicsqPCRsingle-plex assays

Biodesix is a diagnostic solutions company that provides advanced diagnostic tests and custom development services. Its tests support clinical decisions for patients with lung disease, and its development services support biopharmaceutical, life sciences, and research institutions in developing diagnostic tests, tools, and therapeutics. The company operates two certified laboratories and uses its proprietary Diagnostic Cortex bioinformatics platform.

assay validationbioinformatics (Diagnostic Cortex platform)biomarker discoveryclinical trial sample testingcustom assay developmentddPCRgenomic testing and monitoringmulti-omics integrationproteomic testingspatial proteomics with MALDI-IHCspecimen collection kit manufacturing

Cellecta, Inc. is a genomics company based in Mountain View, CA that provides products and services for drug target and biomarker discovery, including CRISPR and RNAi screening libraries, lentiviral constructs, cell barcoding libraries, and transcriptome and adaptive immune receptor profiling kits. The company offers both do-it-yourself and full-service options for targeted and genome-wide screens.

adaptive immune receptor profilingbioinformatics analysiscell line engineeringCRISPR/RNAi screeningcustom library constructionlentiviral vector packagingmultiplex PCRsingle-cell genetic analysistargeted RNA-Seq expression profiling

CD BioSciences is a CRO focused on oncology testing, translational research and clinical diagnostics. It provides advanced pathology services, molecular diagnostic platforms and end-to-end lab solutions including central lab services, preclinical and nonclinical studies, and clinical and regulatory support to accelerate precision medicine development.

AI-assisted image analysisbiobankingcentral laboratory servicesdPCRFISHFlow Cytometryhistopathologyimmunohistochemistry (IHC)liquid biopsy/ctDNAMRD testingmultiplex IHC/IFqPCRRegulatory consultingSanger sequencingwhole slide imaging

Genzera is a biotechnology supplier serving labs across the U.S. and abroad with molecular and synthetic biology reagents and custom research services. Its catalog includes validated antibodies, ELISA kits, nucleic acid extraction kits, PCR reagents, NGS library prep kits, cell culture media, and laboratory equipment, alongside custom services such as gene synthesis, protein expression, and virus packaging.

gene synthesisPCR cloning and subcloningpeptide synthesisplasmid DNA preparationpooled screeningprotein expressionQC, deconvolution & analysisRNA synthesissite-directed mutagenesisvirus packaging

JBS Science, Inc., incorporated in PA in 2011, develops circulating cell-free DNA (cfDNA) in urine technology for cancer screening and management via liquid biopsy. Its proprietary technologies include sensitive qPCR assays for tumor DNA markers using cfDNA in urine and blood, and methods for cfDNA isolation. It offers nucleic acid purification, PCR kits, droplet digital PCR kits, urine collection kits, NGS-related products, and software, and provides HBV-targeted and HCC-targeted NGS services.

cfDNA isolationliquid biopsynucleic acid extractionqPCR assay development